Literature DB >> 34062268

The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases.

Stefano Barbera1, Roberta Lugano2, Alessia Pedalina3, Maurizio Mongiat4, Annalisa Santucci3, Gian Marco Tosi5, Anna Dimberg2, Federico Galvagni3, Maurizio Orlandini6.   

Abstract

Endothelial cell migration is essential to angiogenesis, enabling the outgrowth of new blood vessels both in physiological and pathological contexts. Migration requires the activation of several signaling pathways, the elucidation of which expands the opportunity to develop new drugs to be used in antiangiogenic therapy. In the proliferating endothelium, the interaction between the transmembrane glycoprotein CD93 and the extracellular matrix activates signaling pathways that regulate cell adhesion, migration, and vascular maturation. Here we identify a pathway, comprising CD93, the adaptor proteins Cbl and Crk, and the small GTPases Rac1, Cdc42, and RhoA, which we propose acts as a regulator of cytoskeletal movements responsible for endothelial cell migration. In this framework, phosphorylation of Cbl on tyrosine 774 leads to the interaction with Crk, which acts as a downstream integrator in the CD93-mediated signaling regulating cell polarity and migration. Moreover, confocal microscopy analyses of GTPase biosensors show that CD93 drives coordinated activation of Rho-proteins at the cell edge of migratory endothelial cells. In conclusion, together with the demonstration of the key contribution of CD93 to the migratory process in living cells, these findings suggest that the signaling triggered by CD93 converges to the activation and modulation of the Rho GTPase signaling pathways regulating cell dynamics.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cbl; Cdc42; Crk; Rac1; RhoA

Mesh:

Substances:

Year:  2021        PMID: 34062268     DOI: 10.1016/j.matbio.2021.05.006

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  7 in total

1.  CD93 is Associated with Glioma-related Malignant Processes and Immunosuppressive Cell Infiltration as an Inspiring Biomarker of Survivance.

Authors:  Kaiming Ma; Suhua Chen; Xin Chen; Xiaofang Zhao; Jun Yang
Journal:  J Mol Neurosci       Date:  2022-08-25       Impact factor: 2.866

Review 2.  Regulation of Rac1 Activation in Choroidal Endothelial Cells: Insights into Mechanisms in Age-Related Macular Degeneration.

Authors:  Aniket Ramshekar; Haibo Wang; M Elizabeth Hartnett
Journal:  Cells       Date:  2021-09-14       Impact factor: 7.666

3.  A glimpse into the past: phylogenesis and protein domain analysis of the group XIV of C-type lectins in vertebrates.

Authors:  Stefano Barbera; Claudio Cucini
Journal:  BMC Genomics       Date:  2022-06-04       Impact factor: 4.547

4.  CD93 Signaling via Rho Proteins Drives Cytoskeletal Remodeling in Spreading Endothelial Cells.

Authors:  Stefano Barbera; Luisa Raucci; Roberta Lugano; Gian Marco Tosi; Anna Dimberg; Annalisa Santucci; Federico Galvagni; Maurizio Orlandini
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

5.  Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response.

Authors:  Wen Tong; Guangyu Wang; Liuyang Zhu; Yi Bai; Zirong Liu; Long Yang; Hao Wu; Tao Cui; Yamin Zhang
Journal:  Front Mol Biosci       Date:  2022-02-21

6.  CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.

Authors:  Zerui Zhang; Mengli Zheng; Qiang Ding; Mei Liu
Journal:  Front Cell Dev Biol       Date:  2022-02-15

7.  ARHGEF2/EDN1 pathway participates in ER stress-related drug resistance of hepatocellular carcinoma by promoting angiogenesis and malignant proliferation.

Authors:  Yue Zhu; Weiwei Liu; Zishu Wang; Yanfei Wang; Chaisheng Tan; Zhipeng Pan; Anqi Wang; Jiatao Liu; Guoping Sun
Journal:  Cell Death Dis       Date:  2022-07-27       Impact factor: 9.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.